|

TROP2 ADC Clinical Trials

2 actively recruiting trials

Also known as: Cohort 4 (TROP2 ADC)

Pipeline

Phase 2: 2

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
  • Peking Union Medical College1

Indications

  • Cancer2
  • Precision Therapy1
  • Salivary Gland Carcinoma1
  • Metastatic Triple-Negative Breast Cancer1
  • Breast Cancer1

Other2 trials

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Phase 2
The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.